Contract Research Organisation
Benchmarking Your Pharmaceutical Contract Manufacturing Strategies in 2013
March 13 by Pharma IQ SurveysAs a thank you, all participants who complete the survey by 28th March are automatically entered in a prize draw for a free place at Pharma IQ’s 6th Annual Global Pharma Contract Manufacturing...
Pharma IQ Talking Heads - Global Pharmaceutical Contract Manufacturing Roundtable 2012
February 16 by Pharmaceuticals & Biotechnology EditorContract Manufacturing in Pharmaceuticals continues to increase… Decreasing profits in pharmaceuticals over the past 5 years has put manufacturing and product costs under greater scrutiny....
How Do You Drive Clinical Innovation Without Compromising Quality or Your Relationships?
December 20 by Pharmaceuticals & Biotechnology EditorWith an increase in multiple site trials, risk sharing partnerships and warning letters to CROs on the horizon, Pharma IQ in conjunction with the 3rd Annual Global Clinical Outsourcing Forum ask the...
Choosing a new Clinical Research Partner – How to Decide
November 17 by Pharma IQ SurveysAs a member of the global clinical development community, we are asking for your perceptions and experiences of selecting and working with CROs and other clinical partners. We’d really app...
ActoGenix's Sam Corveleyn: A 4-Step Approach to CMO Selection
September 23 by Pharmaceuticals & Biotechnology EditorDr. Sam Corveleyn, Director CMC and Qualified Person, ActoGenix, speaks to Andrea Charles from Pharma IQ, about mitigating risk in contract manufacturing, a 4-step approach to CMO sel...
Developing Clinical Trials for Oncology Part 2: Outsourcing and Strategic Alliances
September 22 by Pharmaceuticals & Biotechnology Editor[inlinead] Denis Mir, Senior Manager of Clinical Operations in Oncology at Eisai Global Clinical Development, shares his thoughts on outsourcing and strategic alliances in clinical trial...
Pharmaceutical Outsourcing, Where Do You Draw the Line?
May 20 by Cristina FalcãoThe real issue in pharma is budget and structural change. There are no magic methods to overcome what Richard Nelson called "the simple economics of basic scientific research—patents or no patents, ca...
Choosing a New CMO? The Cost of Change is Critical
May 03 by Andrea CharlesRichard Loughlin, Director, Contract Manufacturing Business Development North America, Commercial & External Partnerships (CEPiA) sanofi aventis, joins Andrea Charles from Pharma IQ, to discuss&...
Is Your Clinical Outsourcing Clear?
February 22 by Pharma IQIn the pharmaceutical industry, the majority of companies now outsource the clinical trial process, with a massive 67 per cent of pharma and bio organisations outsourcing more than half of their tri...
Why Are We Going to Move to Another CRO?
February 14 by Richard de Silva[inlinead] Antonio Llamas, Regional Head of Operations in Spain and Portugal for Wyeth Research, joins Pharma IQ, to discuss global clinical outsourcing. To listen to the podcast go to Strategies...
Potential and Capabilities of the Clinical Research Sector
October 06 by Pharma IQClinical research organizations play an essential role in the drug development process. From large international firms to smaller niche companies, clinical research organizations are relied upon by th...
Logistics for Clinical Trials in Emerging Markets
August 19 by Pharma IQMark Walls, Director of Clinical Pharmacy at Human Genome Sciences, speaks to Andrea Charles from Pharma IQ, about the logistical challenges facing clinical trials and avoiding common mistakes for log...